hesperidin has been researched along with Experimental Mammary Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, P; Shah, J | 1 |
| Bansal, AK; Navik, U; Sheokand, S | 1 |
| Balamurugan, A; Balasubramanian, MP; Nandakumar, N; Rengarajan, T | 1 |
| Balasubramanian, MP; Nandakumar, N | 2 |
| Balasubramanian, MP; Jayaprakash, R; Nandakumar, N | 1 |
| Carroll, KK; Chambers, AF; Guthrie, N; Moussa, M; So, FV | 1 |
7 other study(ies) available for hesperidin and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Protective effects of hesperidin through attenuation of Ki67 expression against DMBA-induced breast cancer in female rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinogens; Chemoprevention; Doxorubicin; Female; Hesperidin; Ki-67 Antigen; Mammary Neoplasms, Experimental; Rats; Rats, Wistar | 2021 |
Nanocrystalline solid dispersions (NSD) of hesperetin (HRN) for prevention of 7, 12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in Sprague-Dawley (SD) rats.
Topics: Animals; Anthracenes; Female; Hesperidin; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Nanoparticles; Piperidines; Random Allocation; Rats; Rats, Sprague-Dawley | 2019 |
Modulating effects of hesperidin on key carbohydrate-metabolizing enzymes, lipid profile, and membrane-bound adenosine triphosphatases against 7,12-dimethylbenz(a)anthracene-induced breast carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenosine Triphosphatases; Animals; Carbohydrate Metabolism; Carcinogens; Cell Membrane; Female; Hesperidin; Lipid Metabolism; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley | 2014 |
Hesperidin protects renal and hepatic tissues against free radical-mediated oxidative stress during DMBA-induced experimental breast cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Citric Acid Cycle; Female; Free Radicals; Hesperidin; Kidney; Lipid Peroxidation; Liver; Mammary Neoplasms, Experimental; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley | 2011 |
Influence of hesperidin on renal cell surface glycoprotein content, nucleic acids, lysosomal enzymes and macromolecules against 7, 12-dimethylbenz [a] anthracene induced experimental breast carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Biomarkers; Carcinogens; Female; Glycoproteins; Hesperidin; Kidney; Lipids; Liver; Lysosomes; Macromolecular Substances; Mammary Neoplasms, Experimental; Nucleic Acids; Rats; Rats, Sprague-Dawley | 2012 |
Hesperidin a citrus bioflavonoid modulates hepatic biotransformation enzymes and enhances intrinsic antioxidants in experimental breast cancer rats challenged with 7, 12-dimethylbenz (a) anthracene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antioxidants; Biomarkers; Carcinogens; Cytochrome P-450 Enzyme System; Cytochromes b5; Female; Glutathione; Hesperidin; Mammary Neoplasms, Experimental; NADPH-Ferrihemoprotein Reductase; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2012 |
Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Beverages; Breast Neoplasms; Cell Division; Citrus; Female; Flavanones; Flavonoids; Genistein; Hesperidin; Humans; Isoflavones; Mammary Neoplasms, Experimental; Quercetin; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1996 |